Search Results for "f"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for f. Results 631 to 640 of 864 total matches.
Vamorolone (Agamree) for Duchenne Muscular Dystrophy
The Medical Letter on Drugs and Therapeutics • May 28, 2024 (Issue 5072)
Lett Drugs Ther 2017; 59:153.
2. F Fortunato et al. Innovative therapeutic approaches for
Duchenne ...
The FDA has approved vamorolone (Agamree –
Catalyst), an oral corticosteroid, for treatment of
Duchenne muscular dystrophy (DMD) in patients
≥2 years old. Vamorolone is the second oral
corticosteroid to be approved in the US for treatment
of DMD; deflazacort (Emflaza) was approved in 2017.
Med Lett Drugs Ther. 2024 May 28;66(5072):1-2 doi:10.58347/tml.2024.5072a | Show Introduction Hide Introduction
Fluoxetine (Prozac) and Other Drugs for Treatment of Obesity
The Medical Letter on Drugs and Therapeutics • Nov 25, 1994 (Issue 936)
be irreversible, has
occurred in patients taking fenfluramine (F Brenot et al, Br Heart J, 70:537, 1993 ...
Recent reports have suggested that some obese patients may benefit from long-term pharmacologic treatment (RL Atkinson and VS Hubbard, Am J Clin Nutr, 60:153, August 1994; DJ Goldstein and JH Potvin, Am J Clin Nutr, 60:647, November 1994). Fluoxetine (Prozac), widely used for treatment of depression and near approval by the US Food and Drug Administration (FDA) for treatment of bulimia, is also being tried for treatment of obesity.
Mifepristone (RU 486)
The Medical Letter on Drugs and Therapeutics • Oct 30, 2000 (Issue 1091)
; Dan M. Roden, M.D., Vanderbilt School of Medicine; F. Estelle R. Simons, M.D.,
University of Manitoba ...
Mifepristone (RU 486; Mifeprex - Danco), an antiprogestin, has been approved by the FDA for termination of intrauterine pregnancies of 49 days or less. It is generally used with misoprostol (Cytotec - Searle), an E1 prostaglandin analog marketed in the USA only for prevention of gastric ulcers.
Erythropoietin (Procrit; Epogen) Revisited
The Medical Letter on Drugs and Therapeutics • May 14, 2001 (Issue 1104)
Meinertz, M.D.,
University Hospital, Copenhagen; Dan M. Roden, M.D., Vanderbilt School of Medicine; F ...
Use of epoetin alfa, a recombinant human erythropoietin, is being promoted directly to consumers in vague advertisements that promise renewed energy and improved work capacity. Epoetin is approved by the FDA for treatment of anemia due to chronic renal failure, cancer chemotherapy or HIV treatment, and before elective non-cardiac surgery. It is also used illicitly by competitive athletes to increase their endurance.
Ziprasidone (Geodon) For Schizophrenia
The Medical Letter on Drugs and Therapeutics • Jun 11, 2001 (Issue 1106)
, Copenhagen; Dan M. Roden, M.D., Vanderbilt School of Medicine; F. Estelle R. Simons, M.D., University ...
Ziprasidone (Geodon - Pfizer), a benzisothiazolyl piperazine, has been approved by the FDA for oral treatment of schizophrenia. An intramuscular formulation will probably be available in the near future.
Iodine-131 Tositumomab (Bexxar) for Treatment of Lymphoma
The Medical Letter on Drugs and Therapeutics • Oct 27, 2003 (Issue 1168)
Meinertz, M.D., University Hospital, Copenhagen; Dan M. Roden, M.D., Vanderbilt School of Medicine; F ...
Bexxar, a combination of the monoclonal antibody tositumomab and radiolabeled Iodine-131 tositumomab (Corixa Corp/GlaxoSmithKline) has been approved by the FDA for a single treatment of relapsed follicular non-Hodgkin's lymphoma (NHL) in patients who are refractory to rituximab (Rituxan - Medical Letter 1998; 40:65). It is the second radioimmunoconjugate to be approved for refractory NHL; yttrium-90 linked to ibritumomab tiuxetan (Zevalin) was approved in 2002. Tositumomab, like ibritumomab, is a monoclonal antibody of mouse origin that binds to the CD20 antigen present on the surface of >90%...
Tadalafil (Cialis) for Erectile Dysfunction
The Medical Letter on Drugs and Therapeutics • Dec 22, 2003 (Issue 1172)
. Roden, M.D., Vanderbilt School of Medicine; F. Estelle R. Simons, M.D., University of Manitoba;
Neal H ...
Tadalafil (Cialis - Lilly Icos) is the third oral drug to be approved by the FDA for treatment of erectile dysfunction. It has a longer duration of action than sildenafil (Viagra) or vardenafil (Levitra - Medical Letter 2003; 45:77).
Zolmitriptan (Zomig) Nasal Spray for Migraine
The Medical Letter on Drugs and Therapeutics • Jan 19, 2004 (Issue 1174)
of Medicine; F. Estelle R. Simons, M.D., University of Manitoba;
Neal H. Steigbigel, M.D., New York ...
Zolmitriptan (Zomig - AstraZeneca) nasal spray was recently approved by the FDA for treatment of migraine. It is the second selective serotonin receptor agonist ("triptan") to become available as a nasal spray; sumatriptan has been available in this form since 1997. Some patients with migraine cannot take tablets because of nausea and vomiting, and nasal sprays are more convenient than subcutaneous injections.
Daptomycin (Cubicin) for Skin and Soft Tissue Infections
The Medical Letter on Drugs and Therapeutics • Feb 02, 2004 (Issue 1175)
., University Hospital, Copenhagen; Dan M. Roden, M.D., Vanderbilt School of Medicine; F. Estelle R. Simons, M.D ...
Daptomycin (Cubicin - Cubist), a cyclic lipopeptide (a new class of antibiotics), has been approved by the FDA for intravenous (IV) treatment of complicated skin and skin structure infections. It is being promoted as a once-daily bactericidal alternative to vancomycin (Vancocin, and others) for methicillin-resistant Staphylococcus aureusinfections.
Is Effexor More Effective than an SSRI?
The Medical Letter on Drugs and Therapeutics • Feb 16, 2004 (Issue 1176)
. Roden, M.D., Vanderbilt School of Medicine; F. Estelle R. Simons, M.D., University of Manitoba;
Neal H ...
Venlafaxine (Effexor, Effexor XR - Wyeth), an antidepressant that inhibits both norepinephrine and serotonin reuptake, was first approved by the FDA in 1993. It has been used mainly as a second-line agent for patients who have not responded to a selective serotonin reuptake inhibitor (SSRI). Some Medical Letter consultants have had the clinical impression that venlafaxine is more effective than an SSRI, particularly for patients with severe, classic depression (melancholia), and believe it should be considered a first-line drug (Treatment Guidelines from the Medical Letter 2003, 1:69). Is...